Multidrug resistance: clinical relevance in acute leukemia

scientific article published on October 1993

Multidrug resistance: clinical relevance in acute leukemia is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P698PubMed publication ID7902728

P2093author name stringList AF
P433issue10
P921main subjectmultiple drug resistanceQ643839
P304page(s)23-8, 32; discussion 32, 35-8
P577publication date1993-10-01
P1433published inOncologyQ1998293
P1476titleMultidrug resistance: clinical relevance in acute leukemia
P478volume7

Reverse relations

cites work (P2860)
Q37417569Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
Q55013035Effects of Hypoxia on Biology of Human Leukemia T-cell Line (MOLT-4 cells) Co-cultured with Bone Marrow Mesenchymal Stem Cells.
Q33758413Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)
Q36722841N-(2-Hydroxypropyl)methacrylamide Copolymer-Drug Conjugates for Combination Chemotherapy of Acute Myeloid Leukemia
Q41390124Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells